Chitosan-based biomaterials for the treatment of bone disorders

被引:44
作者
Rahimi, Mahdi [1 ]
Mir, Seyed Mostafa [2 ]
Baghban, Roghayyeh [3 ]
Charmi, Gholamreza [4 ]
Plummer, Christopher M. [5 ]
Shafiei-Irannejad, Vahid [6 ]
Soleymani, Jafar [7 ]
Pietrasik, Joanna [4 ]
机构
[1] Univ Montreal, Hop Sacre Coeur Montreal CIUSSS NIM, Fac Med, Ctr Rech, 5400 Boul Gouin Ouest, Montreal, PQ H4J 1C5, Canada
[2] Golestan Univ Med Sci, Metab Disorders Res Ctr, Gorgan, Iran
[3] Shiraz Univ Med Sci, Poostchi Ophtalmol Res Ctr, Sch Med, Dept Ophtalmol, Shiraz, Iran
[4] Lodz Univ Technol, Inst Polymer & Dye Technol, Fac Chem, Lodz, Poland
[5] Lodz Univ Technol, Int Ctr Res Innovat Biobased Mat ICRI BioM Int Re, Lodz, Poland
[6] Urmia Univ Med Sci, Cellular & Mol Med Inst, Cellular & Mol Res Ctr, Orumiyeh, Iran
[7] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
关键词
Natural polymers; Polysaccharides; Bone-related disease; Chitosan; Biomedical applications; DRUG-DELIVERY SYSTEMS; BETA-TRICALCIUM PHOSPHATE; IN-VITRO; HYALURONIC-ACID; MECHANICAL-PROPERTIES; RHEUMATOID-ARTHRITIS; TARGETED DELIVERY; TNF-ALPHA; BIOMEDICAL APPLICATIONS; ARTICULAR-CARTILAGE;
D O I
10.1016/j.ijbiomac.2022.06.079
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Bone is an alive and dynamic organ that is well-differentiated and originated from mesenchymal tissues. Bone undergoes continuous remodeling during the lifetime of an individual. Although knowledge regarding bones and their disorders has been constantly growing, much attention has been devoted to effective treatments that can be used, both from materials and medical performance points of view. Polymers derived from natural sources, for example polysaccharides, are generally biocompatible and are therefore considered excellent candidates for various biomedical applications. This review outlines the development of chitosan-based biomaterials for the treatment of bone disorders including bone fracture, osteoporosis, osteoarthritis, arthritis rheumatoid, and osteosarcoma. Different examples of chitosan-based formulations in the form of gels, micro/nanoparticles, and films are discussed herein. The work also reviews recent patents and important developments related to the use of chitosan in the treatment of bone disorders. Although most of the cited research was accomplished before reaching the clinical application level, this manuscript summarizes the latest achievements within chitosan-based biomaterials used for the treatment of bone disorders and provides perspectives for future scientific activities.
引用
收藏
页码:346 / 367
页数:22
相关论文
共 311 条
  • [71] FARR M, 1985, CLIN EXP RHEUMATOL, V3, P99
  • [72] Stimuli-responsive chitosan-based nanocarriers for cancer therapy
    Fathi, Marziyeh
    Zangabad, Parham Sahandi
    Majidi, Sima
    Barar, Jaleh
    Erfan-Niya, Hamid
    Omidi, Yadollah
    [J]. BIOIMPACTS, 2017, 7 (04) : 269 - 277
  • [73] Design and optimization of alginate-chitosan-pluronic nanoparticles as a novel meloxicam drug delivery system
    Fattahpour, Shohreh
    Shamanian, Morteza
    Tavakoli, Naser
    Fathi, Mohammadhossein
    Sheykhi, Saeid Reza
    Fattahpour, Shirin
    [J]. JOURNAL OF APPLIED POLYMER SCIENCE, 2015, 132 (28)
  • [74] Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: In vitro and in vivo evaluation
    Feng, Chao
    Wang, Zhiguo
    Jiang, Changqing
    Kong, Ming
    Zhou, Xuan
    Li, Yang
    Cheng, Xiaojie
    Chen, Xiguang
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 457 (01) : 158 - 167
  • [75] Bone-protective effects of nonviral gene therapy with folate-chitosan DNA nanoparticle containing interleukin-1 receptor antagonist gene in rats with adjuvant-induced arthritis
    Fernandes, Julio C.
    Wang, Huijie
    Jreyssaty, Christian
    Benderdour, Mohamed
    Lavigne, Patrick
    Qiu, Xingpin
    Winnik, Francoise M.
    Zhang, Xiaoling
    Dai, Kerong
    Shi, Qin
    [J]. MOLECULAR THERAPY, 2008, 16 (07) : 1243 - 1251
  • [76] Fernández T, 2014, TISSUE ENG PT A, V20, P1948, DOI [10.1089/ten.tea.2013.0696, 10.1089/ten.TEA.2013.0696]
  • [77] Structure function relationships of immunostimulatory polysaccharides: A review
    Ferreira, Sonia S.
    Passos, Claudia P.
    Madureira, Pedro
    Vilanova, Manuel
    Coimbra, Manuel A.
    [J]. CARBOHYDRATE POLYMERS, 2015, 132 : 378 - 396
  • [78] Controlled fluoride release for osteoporosis treatment using orally administered chitosan hydrogels
    Fookes, Federico A.
    Mengatto, Luciano N.
    Rigalli, Alfredo
    Luna, Julio A.
    [J]. JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2019, 51 : 268 - 275
  • [79] Influence of chitosan-tripolyphosphate nanoparticles on thermosensitive polymeric hydrogels: structural organization, drug release mechanisms and cytotoxicity
    Freitas Mariano, Kelli C.
    Monteiro do Nascimento, Monica H.
    Querobino, Samyr M.
    Ramos Campos, Estefania, V
    de Oliveira, Jhones L.
    Yokaichiya, Fabiano
    Franco, Margareth K. K. D.
    Alberto-Silva, Carlos
    de Paula, Eneida
    Lombello, Christiane B.
    de Lima, Renata
    Fraceto, Leonardo F.
    de Araujo, Daniele R.
    [J]. INTERNATIONAL JOURNAL OF POLYMERIC MATERIALS AND POLYMERIC BIOMATERIALS, 2020, 69 (09) : 592 - 603
  • [80] Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024